Government’s 100-day Pledge could slip to 1000 days
Documents released to MCANZ under the official information act show that the regulations associated with the government medical cannabis bill could take years, with a planned go-live of mid-2020. This go-live date is subject to change and with the current under-resourcing of the MOH, it could be considered a best-case scenario. Additionally, an advisory committee initially scheduled for March has been pushed back to November, and may yet be pushed back further.
“It is disappointing that the bill’s second reading has been postponed to November due to haggling around supplementary papers to improve the bill. If the Minister of health had consulted widely in the first place when drafting the bill, we wouldn’t be in this fiasco where essentially anyone who has a stake in the outcome of this bill, whether it’s the patients, the budding industry or indeed the political opposition are all asking for significant amendments to the bill.”
“Patients are left disenfranchised and frustrated with the lack of progress on the bill, and the lack of amendments from the select committee, where the overwhelming majority wished for the exemption to extend to those with severe, chronic and debilitating conditions.”
“It is likely that if things continue as they are, by the time this bill is sorted, nearly 3 years will have passed. Circumstances will have progressed so far that patients will likely be using the referendum as a tool to gain safe legal access, potentially skewing the result in favor”.
“Another issue is the lack of budget at the Ministry of health for external consultation or industry/international experts to assist. We hope that with the surprise surplus government has announced this week, that some of this can be dedicated to setting up the scheme”
“Without additional resources in the near
term, it will prove hard for this potential industry to
catch up with Australia, costing the country in jobs and
revenues, and patients on a cost basis,” Says MCANZ
Coordinator Shane Le